title: [Use of docetaxel in treatment of squamous-cell carcinoma of head and neck].
authors.forename: S
authors.initials: S
authors.lastname: Subramanian
authors.forename: D
authors.initials: D
authors.lastname: Kanagavel
authors.forename: N N
authors.initials: NN
authors.lastname: Petenko
authors.forename: K V
authors.initials: KV
authors.lastname: Orlova
authors.forename: I V
authors.initials: IV
authors.lastname: Samoĭlenko
authors.forename: L V
authors.initials: LV
authors.lastname: Demidov
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D000077143:Docetaxel; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D058990:Molecular Targeted Therapy; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel